Original Source(s)
Related Content
ACP Ranks Obesity Drug Options
A living clinical guideline outlines a treatment hierarchy for selected pharmacologic therapies in patients with obesity and selected patients with overweight.
July 6, 2026
-
4 min
Iron Deficiency Guidance Varies in Premenopausal Women
A Beyond the Guidelines discussion highlighted uncertainty around gastrointestinal evaluation and intravenous iron use in premenopausal women with iron deficiency.
June 11, 2026
-
5 min
ACP Suggests First-Line Obesity Drugs
Semaglutide and tirzepatide had the greatest net benefit among evaluated treatments, the committee concluded.
June 16, 2026
-
5 min